276 related articles for article (PubMed ID: 18614429)
1. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
Khan MK; Khan MF
Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
Khan MK; Khan MF
Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
[TBL] [Abstract][Full Text] [Related]
5. Comparison of high-pressure liquid chromatography and microbiological assay for determination of ciprofloxacin tablets in human plasma employed in bioequivalence and pharmacokinetics study.
Khan MK; Khan MF; Mustafa G; Sualah M
Pak J Pharm Sci; 2012 Jan; 25(1):81-8. PubMed ID: 22186313
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioequivalence evaluation of two brands of ciprofloxacin 500 mg tablets in Iranian healthy volunteers.
Valizadeh H; Hamishehkar H; Ghanbarzadeh S; Zabihian N; Zakeri-Milani P
Arzneimittelforschung; 2012 Dec; 62(12):566-70. PubMed ID: 23047470
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence study of two oral formulations of clarithromycin in human male subjects.
Khan MK; Khan MF; Mustafa G; Sualah M
Pak J Pharm Sci; 2011 Jan; 24(1):43-6. PubMed ID: 21190917
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of two oral ciprofloxacin tablets formulations.
Cuadrado A; Gascón AR; Solinís MA; Ramírez E; Hernández RM; Knie U; Pedraz JL
Int J Clin Pharmacol Ther; 2004 Jun; 42(6):336-41. PubMed ID: 15222727
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
Papich MG
Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
[TBL] [Abstract][Full Text] [Related]
15. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
Shah A; Liu MC; Vaughan D; Heller AH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers.
Mignini F; Tomassoni D; Streccioni V; Traini E; Amenta F
Clin Exp Hypertens; 2008 Feb; 30(2):95-108. PubMed ID: 18293165
[TBL] [Abstract][Full Text] [Related]
17. Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.
Garraffo R; Dellamonica P; Bernard E; Etesse H; Lapalus P
Int J Clin Pharmacol Res; 1989; 9(1):29-35. PubMed ID: 2707923
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of two capsule formulations of omeprazole.
Pillai GK; Salem MS; Najib NM; Jilani J; Hasan MM; Ghanem E; Sallam E; Shubair MS; al-Delq S
Acta Pharm Hung; 1996 Nov; 66(6):231-5. PubMed ID: 9604487
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of two oral formulations of ciprofloxacin.
Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
[No Abstract] [Full Text] [Related]
20. Comparative bioavailability study of clonazepam after oral administration of two tablet formulations.
Chauhan BL; Sane SP; Revankar SN; Rammamurthy L; Doshi B; Bhatt AD; Bhate VR; Kulkarni RD
J Assoc Physicians India; 2000 Oct; 48(10):985-7. PubMed ID: 11200924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
